Autologous plasma transfusion in liver resection for hepatocellular carcinoma

Autologous plasma transfusion in liver resection for hepatocellular carcinoma - Autologous plasma transfusion in liver resection

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001074

Enrollment

100

Registered

2008-03-21

Start date

2006-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma

Interventions

Predeposit autologous plasma donation before liver resection No autologous plasma donation before liver resection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with Child-Pugh class A cirrhosis and indocyanine green retention rate at 15 minutes <= 15%

Exclusion criteria

Exclusion criteria: Patients with a serum albumin level of less than 3.0 g/dL, a hemoglobin level of less than 11.0 g/dL, or a body weight of less than 40 kg

Design outcomes

Primary

Measure	Time frame
Serum total protein/alubumin values and liver synthetic function during plasma donations and perioperative allogenic blood transfusion rates	—

Secondary

Measure	Time frame
Postoperative immune function	—

Countries

Japan

Contacts

Public ContactTakeaki Ishizawa

Graduate School of Medicine, University of Tokyo Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery

tish-tky@umin.ac.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026